Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research.

Biotechnology

Leap Therapeutics

Leap Therapeutics' headquarters in Cambridge, MA, United States

Douglas Onsi

Gus Lawlor

Xieyang Jia

Jonathan Miller

Mike Kagey

Matthew Lederhos

Mark O'Mahony

Christopher Mirabelli

The Research and Scientific Team at Leap Therapeutics is dedicated to advancing innovative cancer therapies through rigorous scientific investigation and clinical development. This multidisciplinary team, led by experts in medical and translational science, collaborates to design and execute clinical trials, analyze data, and translate research findings into actionable treatment strategies, ensuring that breakthrough therapeutics are developed efficiently and effectively.

Research and Scientific Team

The Clinical Development Team at Leap Therapeutics is responsible for designing, planning, and executing clinical trials to evaluate novel cancer therapeutics. This multidisciplinary team collaborates to ensure regulatory compliance, manage clinical data, and oversee trial operations, ultimately aiming to bring innovative treatments to patients efficiently and safely.

Clinical Development Team

The Manufacturing and Operations Team at Leap Therapeutics is responsible for overseeing the development and implementation of efficient manufacturing processes for novel therapeutics. This team ensures that all production adheres to stringent quality control standards, integrates innovative technologies in biomanufacturing, and collaborates across departments to streamline operations, ultimately supporting the timely advancement of cancer research and clinical trials.

Manufacturing and Operations Team

The Data Management and Analysis Team at Leap Therapeutics is responsible for overseeing the collection, organization, and interpretation of clinical trial data. They ensure data integrity and analytics support decision-making processes, while providing financial insights to optimize resource allocation in the development of innovative cancer therapeutics. The team collaboratively works to align data strategies with the company’s business objectives and growth initiatives.

Data Management and Analysis Team

The Regulatory Affairs and Quality Team at Leap Therapeutics is responsible for ensuring compliance with regulatory requirements throughout the drug development process. This team manages submissions to regulatory agencies, oversees Good Clinical Practice (GCP) quality assurance, and coordinates drug safety and pharmacovigilance operations. Their efforts are crucial in maintaining the integrity of clinical trials and ensuring that the company's innovative cancer therapies meet the highest standards of safety and efficacy.

Regulatory Affairs and Quality Team

The Leadership Team at Leap Therapeutics drives strategic decision-making and operational excellence in the pursuit of novel cancer therapeutics. Comprising industry experts such as the Chief Medical Officer and Chief Operating Officer, the team focuses on overseeing clinical development, operational strategies, and manufacturing processes to ensure the successful advancement of innovative treatments from concept to clinical trials.

Leap Therapeutics

Org chart

Board & advisors

Teams

Research and Scientific Team

Clinical Development Team

Manufacturing and Operations Team

Data Management and Analysis Team

Regulatory Affairs and Quality Team

Leadership Team

Offices

Leap Therapeutics

Org chart

Board & advisors

Teams

Research and Scientific Team

Clinical Development Team

Manufacturing and Operations Team

Data Management and Analysis Team

Regulatory Affairs and Quality Team

Leadership Team

Offices

Related companies